ITGB8
Basic information
Region (hg38): 7:20330702-20415754
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITGB8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 36 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 36 | 1 | 1 |
Variants in ITGB8
This is a list of pathogenic ClinVar variants found in the ITGB8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-20331825-G-A | not specified | Uncertain significance (Jan 18, 2023) | ||
7-20331922-T-C | not specified | Uncertain significance (Jul 14, 2021) | ||
7-20331928-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
7-20331938-G-GTTGTT | Benign (Jan 10, 2021) | |||
7-20363688-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
7-20367039-G-A | not specified | Uncertain significance (Nov 29, 2021) | ||
7-20367043-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
7-20367094-T-C | not specified | Uncertain significance (Dec 18, 2023) | ||
7-20367171-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
7-20379056-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
7-20379167-G-A | not specified | Uncertain significance (Apr 20, 2023) | ||
7-20379171-G-C | not specified | Uncertain significance (Sep 16, 2021) | ||
7-20379176-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
7-20379206-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
7-20380721-A-T | not specified | Uncertain significance (Sep 14, 2023) | ||
7-20381814-G-T | not specified | Uncertain significance (Aug 01, 2022) | ||
7-20381839-G-C | not specified | Uncertain significance (Jun 29, 2023) | ||
7-20394905-C-A | not specified | Uncertain significance (Jun 22, 2021) | ||
7-20394930-G-A | not specified | Uncertain significance (Aug 01, 2022) | ||
7-20394937-A-G | not specified | Uncertain significance (Jan 04, 2022) | ||
7-20398926-G-A | not specified | Uncertain significance (Nov 22, 2023) | ||
7-20398935-C-A | not specified | Uncertain significance (Oct 26, 2022) | ||
7-20401746-T-C | not specified | Uncertain significance (May 07, 2024) | ||
7-20401796-A-G | not specified | Uncertain significance (Sep 29, 2023) | ||
7-20401814-G-A | not specified | Likely benign (Jul 21, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ITGB8 | protein_coding | protein_coding | ENST00000222573 | 14 | 85053 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00233 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.931 | 363 | 416 | 0.872 | 0.0000210 | 5072 |
Missense in Polyphen | 98 | 154.24 | 0.63536 | 1804 | ||
Synonymous | 0.572 | 141 | 150 | 0.941 | 0.00000810 | 1410 |
Loss of Function | 5.11 | 5 | 39.8 | 0.126 | 0.00000198 | 508 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000710 | 0.0000703 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Integrin alpha-V:beta-8 (ITGAV:ITGB8) is a receptor for fibronectin (PubMed:1918072). It recognizes the sequence R-G-D in its ligands (PubMed:1918072). Integrin alpha-V:beta-6 (ITGAV:ITGB6) mediates R-G-D-dependent release of transforming growth factor beta-1 (TGF-beta-1) from regulatory Latency- associated peptide (LAP), thereby playing a key role in TGF-beta-1 activation on the surface of activated regulatory T-cells (Tregs) (Probable). Required during vasculogenesis (By similarity). {ECO:0000250|UniProtKB:Q0VBD0, ECO:0000269|PubMed:1918072, ECO:0000305|PubMed:22278742}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Cell adhesion molecules (CAMs) - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Integrin-mediated Cell Adhesion;Arrhythmogenic Right Ventricular Cardiomyopathy;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Integrin cell surface interactions;Extracellular matrix organization;Molecules associated with elastic fibres;Elastic fibre formation;Integrin;Beta5 beta6 beta7 and beta8 integrin cell surface interactions
(Consensus)
Recessive Scores
- pRec
- 0.220
Intolerance Scores
- loftool
- 0.0237
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.88
Haploinsufficiency Scores
- pHI
- 0.373
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.561
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.337
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Itgb8
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); craniofacial phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- itgb8
- Affected structure
- brain vasculature
- Phenotype tag
- abnormal
- Phenotype quality
- broken
Gene ontology
- Biological process
- vasculogenesis;ganglioside metabolic process;cell adhesion;cell-matrix adhesion;integrin-mediated signaling pathway;positive regulation of gene expression;negative regulation of gene expression;cell migration;extracellular matrix organization;cell adhesion mediated by integrin;positive regulation of angiogenesis;cartilage development;placenta blood vessel development;regulation of transforming growth factor beta activation
- Cellular component
- plasma membrane;focal adhesion;integrin complex;cell surface;integrin alphav-beta8 complex;extracellular exosome
- Molecular function
- integrin binding;signaling receptor activity;extracellular matrix protein binding